Updated:
DongKoo Bio&Pharma
DongKoo Bio&Pharma was established in 1983 by the late Cho Dong-seop. Cho Yong-joon, second-generation owner, now leads as Chairman and CEO with his mother Lee...
DongKoo Bio&Pharma
DongKoo Bio&Pharma was established in 1983 by the late Cho Dong-seop. Cho Yong-joon, second-generation owner, now leads as Chairman and CEO with his mother Lee Kyung-ok serving as Honorary Chairwoman. The firm pursues a balanced strategy that spans buyouts, early-stage seed and start-up investments, expansion and late-stage rounds, and general venture activity. It maintains a geographic focus on South Korea with one documented joint venture through LVMC Holdings in Laos. Confirmed operational footprints include its headquarters in Seoul plus R&D and manufacturing facilities in Gyeonggi-do. The company lists 179.75 million USD in assets under management on an internal estimate basis. It maintains membership in the Korea Pharmaceutical Cooperative Association, where Cho Yong-joon serves as Chairman, and the Korea Pharmaceutical and Bio-Pharma Manufacturers Association. Cho family ownership and direct operational control of manufacturing assets distinguish the structure from pure financial investors.
General information
Firm type
Corporate Investor
Year founded
1983
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
14th Floor, Building B, 114 Beobwon-ro, Songpa-gu, Seoul, South Korea
Additional offices
Anyang-si, Gyeonggi-do, South Korea · Hwaseong-si, Gyeonggi-do, South Korea
Principals
Cho Yong-joon
Chairman and CEO
Lee Kyung-ok
Honorary Chairwoman
Cho Dong-seop
Late founder
Sector focus
Frequently asked questions
Who runs investment decisions at DongKoo Bio&Pharma?
Cho Yong-joon serves as Chairman and CEO and oversees the firm's investment activity.
What asset classes does DongKoo Bio&Pharma target?
The firm allocates across buyouts, early-stage seed and start-up rounds, expansion and late-stage deals, and general venture investments.
Does DongKoo Bio&Pharma participate in fund commitments or direct deals?
Available records show both direct investments and at least one joint-venture structure with LVMC Holdings.
Where does DongKoo Bio&Pharma maintain operations?
Headquarters sit in Seoul with additional R&D and manufacturing sites in Anyang-si and Hwaseong-si, Gyeonggi-do.
What industry associations does the firm belong to?
DongKoo Bio&Pharma participates in the Korea Pharmaceutical Cooperative Association and the Korea Pharmaceutical and Bio-Pharma Manufacturers Association.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: